H.C. Wainwright on Cytokinetics (CYTK): 'Less Restrictive Label for Camzyos in oHCM; We Still Project Cleaner Label for Aficamten; Reiterate Top Pick'
Tweet Send to a Friend
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating and $120.00 price target on Cytokinetics (NASDAQ: CYTK).The analyst comments "Camzyos ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
